Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-06-12

Clinical Trial Update: Humira in Rheumatoid Arthritis - Do Bone Erosions Heal? [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Humira (adalimumab) for rheumatoid arthritis and potential healing of bone erosions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humira (adalimumab)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Rheumatoid Arthritis, Arthritis | Phase 4 | Status: COMPLETED